Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome

American Journal of Surgical Pathology

Volumn 29, Issue 7, 2005, Pages 903-911

  Maric, Irina ^a,c   Pittaluga, Stefania ^a   Dale, Janet K ^b   Niemela, Julie E ^c   Delsol, Georges ^d   Diment, Judith ^e,g   Rosai, Juan ^e   Raffeld, Mark ^a   Puck, Jennifer M ^f   Straus, Stephen E ^b   Jaffe, Elaine S ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d CHU PURPAN   (France)

^e NATIONAL CANCER INSTITUTE   (Italy)

^f NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^g KAPLAN MEDICAL CENTER   (Israel)

Author keywords

Apoptosis; Autoimmune disease; Autoimmune lymphoproliferative syndrome; Emperipolesis; Fas gene; Histiocytoses; Rosai Dorfman disease; Sinus histiocytosis with massive lymphadenopathy

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN; EOSIN; FAS ANTIGEN; HEMATOXYLIN;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; GENE MUTATION; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; MALE; ROSAI DORFMAN DISEASE; SINUS HISTIOCYTOSIS; T LYMPHOCYTE;

ADOLESCENT; ADULT; ANTIGENS, CD95; AUTOIMMUNE DISEASES; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTIOCYTOSIS, SINUS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; LYMPH NODES; LYMPHATIC DISEASES; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 21244462801     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000157997.61177.08     Document Type: Article

References (36)

1. Bonetti F, Chilosi M, Menestrina F, et al. Immunohistological analysis of Rosai-Dorfman histiocytosis: a disease of S-100 + CD1-histiocytes. Virchows Arch A Pathol Anat Histopathol. 1987;411:129-135.
2. Canale VC, Smith CH. Chronic lymphadenopathy simulating malignant lymphoma. J Pediatr. 1967;70:891-899.
3. Chun HJ, Zheng LX, Ahmad M, et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature. 2002;419:395-399.
4. Drappa J, Vaishnaw AK, Sullivan KE, et al. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med. 1996;335:1643-1649.
5. Eisen RN, Buckley PJ, Rosai J. Immunophenotypic characterization of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Semin Diagn Pathol. 1990;7:74-82.
6. Eslick J, Scatizzi JC, Albee L, et al. IL-4 and IL-10 inhibition of spontaneous monocyte apoptosis is associated with Flip upregulation. Inflammation. 2004;28:139-145.
7. Fisher GH, Rosenberg FJ, Straus SE, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 1995;81:935-946.
8. Fixe P, Praloran V. M-CSF: haematopoietic growth factor or inflammatory cytokine? Cytokine. 1998;10:32-37.
9. Foucar E, Rosai J, Dorfman RF, et al. Immunologic abnormalities and their significance in sinus histiocytosis with massive lymphadenopathy. Am J Clin Pathol. 1984;82:515-525.
10. Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol. 1990;7:19-73.
11. Fuss IJ, Strober W, Dale JK, et al. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity. J Immunol. 1997;158:1912-1918.
12. George T, Ma L, Nagy P, et al. TNFRSF6 (Fas antigen) mutations in patients with sinus histiocytosis with massive lymphadenopathy. Blood. 2004;104(suppl.):2389a.
13. Goldman FD, Vibhakar R, Puck JM, et al. Aberrant T-cell antigen receptor-mediated responses in autoimmune lymphoproliferative syndrome. Clin Immunol. 2002;104:31-39.
14. Grabczynska SA, Toh CT, Francis N, et al. Rosai-Dorfman disease complicated by autoimmune haemolytic anaemia: case report and review of a multisystem disease with cutaneous infiltrates. Br J Dermatol. 2001; 145:323-326.
15. Holzelova E, Vonarbourg C, Stolzenberg MC, et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med. 2004;351:1409-1418.
16. Infante AJ, Britton HA, DeNapoli T, et al. The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis. J Pediatr. 1998;133:629-633.
17. Jackson CE, Fischer RE, Hsu AP, et al. Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am J Hum Genet. 1999;64:1002-1014.
18. Ju ST, Panka DJ, Cui H, et al. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 1995;373:444-448.
19. Karpas A, Worman C, Arno J, et al. Sinus histiocytosis with massive lymphadenopathy: virological, immunological and morphological studies. Br J Haematol. 1980;45:195-200.
20. Kwon SW, Procter J, Dale JK, et al. Neutrophil and platelet antibodies in autoimmune lymphoproliferative syndrome. Vox Sang. 2003;85:307-312.
21. Le Deist F, Emile JF, Rieux-Laucat F, et al. Clinical, immunological, and pathological consequences of Fas-deficient conditions. Lancet. 1996;348: 719-723.
22. Levine PH, Jahan N, Murari P, et al. Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). J Infect Dis. 1992;166:291-295.
23. Lim M, Straus SE, Dale J, et al. Pathologic findings in human autoimmune lymphoproliferative syndrome. Am J Pathol. 1998;153:1541-1550.
24. Lopatin U, Yao X, Williams RK, et al. Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood. 2001;97:3161-3170.
25. Lu D, Estalilla OC, Manning JT Jr, et al. Sinus histiocytosis with massive lymphadenopathy and malignant lymphoma involving the same lymph node: a report of four cases and review of the literature. Mod Pathol. 2000; 13:414-419.
26. Maennle DL, Grierson HL, Gnarra DG, et al. Sinus histiocytosis with massive lymphadenopathy: a spectrum of disease associated with immune dysfunction. Pediatr Pathol 1991;11:399-412.
27. Martinez A, Pittaluga S, Villamor N, et al. Clonal T-cell populations and increased risk for cytotoxic T-cell lymphomas in B-CLL patients: clinicopathologic observations and molecular analysis. Am J Surg Pathol. 2004;28:849-858.
28. Middel P, Hemmerlein B, Fayyazi A, et al. Sinus histiocytosis with massive lymphadenopathy: evidence for its relationship to macrophages and for a cytokine-related disorder. Histopathology. 1999;35:525-533.
29. Paulli M, Bergamaschi G, Tonon L, et al. Evidence for a polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Br J Haematol. 1995;91:415-418.
30. Plaxico DT, Wray BB, Hsia S, et al. Sinus histiocytosis with massive lymphadenopathy: an immunologic assessment. South Med J. 1982;75: 346-348.
31. Rieux-Laucat F, Le Deist F, Hivroz C, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science. 1995;268:1347-1349.
32. Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy: a newly recognized benign clinicopathological entity. Arch Pathol. 1969; 87:63-70.
33. Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy: a pseudolymphomatous benign disorder. Analysis of 34 cases. Cancer. 1972;30:1174-1188.
34. Sneller MC, Wang J, Dale JK, et al. Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood. 1997;89:1341-1348.
35. Straus SE, Jaffe ES, Puck JM, et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood. 2001;98:194-200.
36. Wang J, Zheng L, Lobito A, et al. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell. 1999;98:47-58.